Differential analysis of peripheral blood- and bone marrow-derived endothelial progenitor cells for enhanced vascularization in bone tissue engineering

Journal of Orthopaedic Research

Volumn 30, Issue 9, 2012, Pages 1507-1515

  Amini, Ami R ^a   Laurencin, Cato T ^a,b   Nukavarapu, Syam P ^a,b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

bone tissue engineering; endothelial progenitor cells; vascularization

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CD31 ANTIGEN; CELL MARKER; VASCULOTROPIN;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BLOOD ANALYSIS; BONE DEVELOPMENT; BONE MARROW; BONE REGENERATION; BONE REMODELING; BONE TISSUE; CELL ISOLATION; CELL POPULATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE ENGINEERING; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

ADULT STEM CELLS; ALKALINE PHOSPHATASE; ANIMALS; BLOOD CELLS; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LAMININ; MESENCHYMAL STEM CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; PHENOTYPE; PROTEOGLYCANS; RABBITS; TISSUE ENGINEERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84863816833     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22097     Document Type: Article

References (31)

1. Laurencin CT, Ambrosio AM, Borden MD, et al. 1999. Tissue engineering: orthopedic applications. Annu Rev Biomed Eng 1: 19-46. (Pubitemid 129740004)
2. Muschler GF, Nakamoto C, Griffith LG., 2004. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am 86-A: 1541-1558. (Pubitemid 38886548)
3. Nukavarapu SP, Wallace J, Elgendy H, et al. 2011. Bone and biomaterials. An introduction to biomaterials and their applications: Taylor & Francis Group. Chapter 29.
4. Santos MI, Reis RL., 2010. Vascularization in bone tissue engineering: physiology, current strategies, major hurdles and future challenges. Macromol Biosci 10: 12-27.
5. Nukavarapu SP, Amini AR., 2011. Optimal Scaffolds and effective progenitor cells for the regeneration of vascularized bone. 33rd Annual International IEEE Engineering in Medicine and Biology Society Conference. Boston, MA, USA.
6. Nukavarapu SP, Amini AR, Wallace JS., 2011. Short-term and long-term effects of orthopedic biodegradable implants. J Long Term Eff Med Implants 21: 93-122.
7. Rouwkema J, Westerweel P, de Boer J, et al. 2009. The use of endothelial progenitor cells for prevascularized bone tissue engineering. Tissue Eng Part A 15: 2015-2027.
8. Rozen N, Bick T, Bajayo A, et al. 2009. Transplanted blood-derived endothelial progenitor cells (EPC) enhance bridging of sheep tibia critical size defects. Bone 45: 918-924.
9. Seebach C, Henrich D, Kähling C, et al. 2010. Endothelial progenitor cells and mesenchymal stem cells seeded onto beta-TCP granules enhance early vascularization and bone healing in a critical-sized bone defect in rats. Tissue Eng Part A 16: 1961-1970.
10. Atesok K, Li R, Stewart DJ, et al. 2010. Endothelial progenitor cells promote fracture healing in a segmental bone defect model. J Orthop Res 28: 1007-1014.
11. Schechner JS, Nath AK, Zheng L, et al. 2000. In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proc Natl Acad Sci USA 97: 9191-9196. (Pubitemid 30626696)
12. Kim S, von Recum H., 2008. Endothelial stem cells and precursors for tissue engineering: cell source, differentiation, selection, and application. Tissue Eng Part B Rev 14: 133-147.
13. Boo L, Selvaratnam L, Tai CC, et al. 2011. Expansion and preservation of multipotentiality of rabbit bone-marrow derived mesenchymal stem cells in dextran-based microcarrier spin culture. J Mater Sci Mater Med 22: 1343-1356.
14. Fedorovich NE, Haverslag RT, Dhert WJ, et al. 2010. The role of endothelial progenitor cells in prevascularized bone tissue engineering: development of heterogeneous constructs. Tissue Eng Part A 16: 2355-2367.
15. Sreejayan N, Yang X., 2007. Isolation and functional studies of rat aortic smooth muscle cells. Methods Mol Med 139: 283-292.
16. Lo K, Kan H, Ashe K, et al. 2011. The small molecule PKA-specific cyclic AMP analogue as an inducer of osteoblast-like cells differentiation and mineralization. J Tiss Eng Reg Med 6: 40-48.
17. Asahara T, Kawamoto A., 2004. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 287: C572-C579. (Pubitemid 39095841)
18. Hristov M, Erl W, Weber PC., 2003. Endothelial progenitor cells: isolation and characterization. Trends Cardiovasc Med 13: 201-206. (Pubitemid 36802024)
19. Ingram DA, Mead LE, Tanaka H, et al. 2004. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104: 2752-2760. (Pubitemid 39434958)
20. Fuchs S, Ghanaati S, Orth C, et al. 2009. Contribution of outgrowth endothelial cells from human peripheral blood on in vivo vascularization of bone tissue engineered constructs based on starch polycaprolactone scaffolds. Biomaterials 30: 526-534.
21. Fuchs S, Jiang X, Schmidt H, et al. 2009. Dynamic processes involved in the pre-vascularization of silk fibroin constructs for bone regeneration using outgrowth endothelial cells. Biomaterials 30: 1329-1338.
22. Fuchs S, Motta A, Migliaresi C, et al. 2006. Outgrowth endothelial cells isolated and expanded from human peripheral blood progenitor cells as a potential source of autologous cells for endothelialization of silk fibroin biomaterials. Biomaterials 27: 5399-5408. (Pubitemid 44093717)
23. Fuchs S, Hermanns MI, Kirkpatrick CJ., 2006. Retention of a differentiated endothelial phenotype by outgrowth endothelial cells isolated from human peripheral blood and expanded in long-term cultures. Cell Tissue Res 326: 79-92. (Pubitemid 44162540)
24. Fuchs S, Dohle E, Kolbe M, et al. 2010. Outgrowth endothelial cells: sources, characteristics and potential applications in tissue engineering and regenerative medicine. Adv Biochem Eng Biotechnol 123: 201-217.
25. Kanczler JM, Oreffo RO., 2008. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 15: 100-114. (Pubitemid 351955734)
26. Villars F, Guillotin B, Amédée T, et al. 2002. Effect of HUVEC on human osteoprogenitor cell differentiation needs heterotypic gap junction communication. Am J Physiol Cell Physiol 282: C775-C785. (Pubitemid 34663140)
27. Yu H, Vandevord P, Gong W, et al. 2008. Promotion of osteogenesis in tissue-engineered bone by pre-seeding endothelial progenitor cells-derived endothelial cells. J Orthop Res 26: 1147-1152.
28. Geuze RE, Wegman F, Oner FC, et al. 2009. Influence of endothelial progenitor cells and platelet gel on tissue-engineered bone ectopically in goats. Tissue Eng Part A 15: 3669-3677.
29. Moonen JR, Krenning G, Brinker MG, et al. 2010. Endothelial progenitor cells give rise to pro-angiogenic smooth muscle-like progeny. Cardiovasc Res 86: 506-515.
30. Díez M, Musri MM, Ferrer E, et al. 2010. Endothelial progenitor cells undergo an endothelial-to-mesenchymal transition-like process mediated by TGFbetaRI. Cardiovasc Res 88: 502-511.
31. Brighton CT, Lorich DG, Kupcha R, et al. 1992. The pericyte as a possible osteoblast progenitor cell. Clin Orthop Relat Res 275: 287-299.